ClinicalTrials.Veeva

Menu

Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA

DePuy Synthes logo

DePuy Synthes

Status

Completed

Conditions

Other Inflammatory Arthritis
Osteoarthritis
Juvenile Rheumatoid Arthritis
Post-Traumatic Arthritis
Avascular Necrosis
Rheumatoid Arthritis

Treatments

Device: Total Knee Arthroplasty
Device: Total knee replacement

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The study will evaluate the clinical performance of the rotating platform and fixed bearing implants through patient questionnaires, outcomes scoring and radiographic assessment.

Full description

The study will evaluate the clinical performance of rotating platform and fixed bearing cruciate ligament substituting implants by obtaining a series of primary TKAS. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System or P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System and assignment is randomized.

Enrollment

149 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Osteoarthritis
  • Rheumatoid arthritis
  • Other inflammatory arthritis
  • Avascular necrosis (AVN) of bone
  • Post-Traumatic Arthritis
  • Juvenile Rheumatoid Arthritis

Exclusion criteria

  • History of recent/active joint sepsis.
  • Charcot neuropathy.
  • Psycho-social disorders that would limit rehabilitation.
  • Greater than 75 years of age at the time of surgery.
  • Prior ipsilateral knee arthroplasty.
  • Metabolic disorders of calcified tissues, such as Paget's disease.
  • Severe diabetes mellitus.
  • Joint replacement due to autoimmune disorders.
  • Skeletal immaturity

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

149 participants in 2 patient groups

1
Active Comparator group
Description:
P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System
Treatment:
Device: Total Knee Arthroplasty
2
Active Comparator group
Description:
P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System
Treatment:
Device: Total knee replacement

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems